Table 2.
Demographic characteristics of the study population
| Total n (%) | Bacterial coinfection (n) | Without bacterial coinfection (n) | |
|---|---|---|---|
| Study patients (n) | 28 (100) | 7 | 21 |
| Male | 17 (60.7) | 5 | 12 |
| Age (years) median [ICR] | 62 [50 to 76] | 62 [61 to 83] | 62 [48 to 75] |
| Comorbidities | |||
| COPD | 3 (10.7) | 1 | 2 |
| Asthma | 3 (10.7) | 0 | 3 |
| Heart failure | 2 (7.1) | 1 | 1 |
| Alcoholism | 3 (10.7) | 0 | 3 |
| Immunosuppression | 7 (25.0) | 2 | 5 |
| No comorbidities | 11 (39.3) | 3 | 8 |
| Clinical manifestations | |||
| Fever | 19 (67.9) | 6 | 13 |
| Cough | 25 (89.3) | 6 | 19 |
| Purulent secretions | 19 (67.9) | 5 | 14 |
| Dyspnea | 20 (71.4) | 5 | 15 |
| Radiologic pattern | |||
| Alveolar | 15 (53.6) | 6 | 9 |
| Interstitial | 3 (10.7) | 1 | 2 |
| Interstitial alveolar | 10 (35.7) | 0 | 10 |
| Bilateral | 17 (60.7) | 2 | 15 |
| Pleural effusion | 8 (28.6) | 2 | 6 |
| Complete blood count | |||
| Leukopenia/leukocytosis/mm3 (< 4000 year > 11,000) | 16 (57.1) | 4 | 12 |
| Thrombocytopenia/mm3 (< 150,000) | 9 (32.1) | 4 | 5 |
| Lymphopenia/mm3 (< 1000) | 23 (82.1) | 6 | 17 |
COPD chronic obstructive pulmonary disease